Medical Cannabis Laws and Safety in the UK 2025 – Key Rules, Risks, and Disclaimers

A Note on Safety We built medicinal-use.com to help make sense of the UK’s changing laws, but we aren’t doctors. This content is for research and education—it isn’t medical advice. Before changing your healthcare routine or starting a new treatment, please speak with a GMC-registered clinician. Your safety matters more than any article we write.

Important Disclaimer
This article is for educational purposes only. It is not legal advice, medical advice, or a substitute for professional guidance. Cannabis-based products for medicinal use (CBPMs) are prescription-only medicines. Possession without a valid prescription is illegal. Always consult a specialist doctor and check current UK law (GMC, MHRA, Home Office, DVLA). Laws change; this reflects status as of December 2025.

1. Legal Status of Medical Cannabis in the UK

Rescheduling (2018): Cannabis was moved to Schedule 2 under the Misuse of Drugs Regulations 2001, allowing specialist doctors to prescribe CBPMs for medicinal use.
Prescription-only: CBPMs are Class B controlled drugs (Schedule 2). Only GMC-registered specialist doctors can prescribe unlicensed CBPMs.
Recreational use: Remains illegal (Class B). Possession, cultivation, and supply without licence are criminal offences.
CBD products: Legal if they meet FSA novel foods rules (<0.2% THC, no medicinal claims). Prescription CBD (e.g., Epidyolex) is different.

2. Who Can Prescribe and Access CBPMs?

Prescribers: Only doctors on the GMC Specialist Register. GPs cannot prescribe directly but may refer.
NHS: Extremely limited (NICE-approved only for specific indications like MS spasticity or rare epilepsies).
Private clinics: Main access route. Patients self-refer, pay privately, and receive prescriptions from specialists.
Import/possession: Patients can possess CBPMs with a valid prescription. Import requires Home Office licence in some cases.

3. Driving and Road Safety Laws

DVLA rules: Strict. THC-containing CBPMs can impair driving. You must:
Not drive within impairment windows (typically 24 hours after use for some products).
Declare use to DVLA if it affects driving safety.
Carry prescription and original packaging.
Roadside testing: Police can test for THC (legal limit is effectively zero for unlicensed use; prescription may offer defence if no impairment).
Penalties: Driving under influence of drugs (including prescribed CBPMs if impaired) can lead to disqualification, fines, and points.

4. Possession and Legal Risks

With prescription: Legal to possess, store, and use as directed. Keep original packaging and prescription copy.
Without prescription: Class B offence — possession up to 7 years prison (rare for small amounts), but still criminal.
Travel: Check destination country laws (many ban cannabis even if prescribed). UK airports may require documentation.

5. Safety Considerations

Side effects: Dry mouth, fatigue, dizziness, appetite changes (CBD lower risk). THC: potential anxiety/paranoia, dependence, cognitive effects.
Interactions: Can interact with antidepressants, sedatives, blood thinners, etc.
Long-term: Limited data on prolonged use; monitor for tolerance or psychiatric effects.
Vulnerable groups: Avoid in pregnancy, breastfeeding, psychosis history, or young people unless specialist-approved.

6. Key Regulations and Oversight

MHRA: Regulates CBPMs as medicines (unlicensed but allowable).
CQC: Regulates private clinics.
GMC: Sets prescribing standards for specialists.
Home Office: Controls rescheduling and import licences.

Sources

Misuse of Drugs Regulations 2001 (Schedule 2)
GMC guidance on CBPM prescribing
DVLA medical standards for driving with prescribed controlled drugs
NICE CBPM guidelines
MHRA and Home Office statements